Home › Steatotic Liver Disease › New York › New York City
Pag-aaral pangklinika para sa Steatotic Liver Disease sa New York City, NY
16 pag-aaral para sa Steatotic Liver Disease ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng New York City (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Nagre-recruitPhase 3
- 89bio Clinical Study Site, New York
- 89bio Clinical Study Site, New York
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Nagre-recruitPhase 3
- 89bio Clinical Study Site, New York
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
Nagre-recruitPhase 3
- GSK Investigational Site, New York
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Nagre-recruitPhase 2
- New York Presbyterian/Weill Cornell, New York
- Columbia University Iriving School of Medicine, New York
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Nagre-recruitPhase 2
- Columbia University Irving Medical Center, New York
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Nagre-recruitPhase 3
- NYU Langone Health, New York
- IMA Clinical Research Manhattan, New York
- New York Gastroenterology Associates, New York
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Nagre-recruitPhase 3
- Akero Clinical Study Site, New York
- Akero Clinical Study Site, New York
- Akero Clinical Study Site, New York
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Nagre-recruitPhase 3
- GSK Investigational Site, New York
Human Models of Selective Insulin Resistance: Alpelisib, Part I
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
- Columbia University Irving Medical Center, New York
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
Nagre-recruitPhase 2
- GSK Investigational Site, New York
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Nagre-recruitPhase 3
- GSK Investigational Site, New York
- GSK Investigational Site, New York
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Nagre-recruitPhase 2
- GSK Investigational Site, New York
Effect of Insulin Lowering on Lipogenesis
Nagre-recruitPhase 1
- Columbia University Irving Medical Center, New York
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
Nagre-recruit
- Icahn School of Medicine at Mount Sinai, New York
Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Weill Cornell Medicine, New York
High Fructose Diet, the Gut Microbiome, and Metabolic Health
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Mount Sinai Morningside, New York
Pag-aaral para sa Steatotic Liver Disease sa ibang lungsod
- San Antonio, TX17 pag-aaral
- Miami, FL16 pag-aaral
- San Diego, CA14 pag-aaral
- Austin, TX13 pag-aaral
- Houston, TX13 pag-aaral
- Richmond, VA12 pag-aaral
- Chandler, AZ10 pag-aaral
- Tucson, AZ10 pag-aaral
- Orlando, FL9 pag-aaral
- Dallas, TX9 pag-aaral
- St. Louis, MO9 pag-aaral
- Hialeah, FL9 pag-aaral
Iba pang pag-aaral sa New York City
- Kanser sa Suso136 pag-aaral
- Non-Small Cell Lung Cancer121 pag-aaral
- Kanser (lahat ng uri)109 pag-aaral
- Kanser sa Prostate103 pag-aaral
- Metastatic Cancer93 pag-aaral
- Colorectal Cancer78 pag-aaral
- Kanser sa Ovary69 pag-aaral
- Kanser sa Baga60 pag-aaral
- Multiple Myeloma60 pag-aaral
- Kanser sa Pancreas60 pag-aaral
- Kanser ng Endometrium52 pag-aaral
- Acute Myeloid Leukemia51 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.